Nalaganje...
3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis
BACKGROUND: Concurrent chemoradiotherapy with cisplatin is standard for patients (pts) with loco-regionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) and for patients with resected SCCHN with high-risk features. The standard regimen includes 3-weekly cisplatin, but weekly regi...
Shranjeno v:
| izdano v: | Radiat Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6371614/ https://ncbi.nlm.nih.gov/pubmed/30744643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1235-y |
| Oznake: |
Označite
Brez oznak, prvi označite!
|